EyeCRO

Oklahoma City, United States Founded: 2011 • Age: 15 yrs
Provider of in vivo and in vitro models for ophthalmic research
Request Access

About EyeCRO

EyeCRO is a company based in Oklahoma City (United States) founded in 2011.. EyeCRO offers products and services including MiDROPS®, Preclinical Models, and Toxicology Services. EyeCRO operates in a competitive market with competitors including Lexitas, Experimentica, Humonix Biosciences, Optimal Tracers and Ophthy-DS, among others.

  • Headquarter Oklahoma City, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $185.55 K (USD), Grant

    Sep 01, 2016

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of EyeCRO

EyeCRO offers a comprehensive portfolio of products and services, including MiDROPS®, Preclinical Models, and Toxicology Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Microemulsion platform for eyedrop formulations of lipophilic drugs.

Models for testing eye diseases like dry eye and retinal disorders.

Studies for pharmacokinetics and safety in ophthalmic research.

People of EyeCRO
Headcount 10-50
Employee Profiles 5
Employee Profiles
People
Connor Hodde, CPA
Vice President of Finance
People
Alexander Q.
Sr. Vice President
People
Terry G. Coursey, PhD
Vice President, Science and Discovery
People
Phillip Vanlandingham, Ph.D.
Vice President of Translational Research

Unlock access to complete

Teams

Funding Insights of EyeCRO

  • Total Funding
  • Total Rounds 19
  • Last Round Grant — $185,550
  • First Round

    (01 Sep 2006)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2016 Amount Grant - EyeCRO Valuation

investors

Aug, 2015 Amount Grant - EyeCRO Valuation

investors

Mar, 2013 Amount Grant - EyeCRO Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in EyeCRO

EyeCRO has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by EyeCRO

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - EyeCRO

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Eyecro Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of EyeCRO

EyeCRO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lexitas, Experimentica, Humonix Biosciences, Optimal Tracers and Ophthy-DS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Clinical trials and medical strategies for ophthalmology products are provided.
domain founded_year HQ Location
Developing in vitro, ex vivo and in vivo preclinical ocular models
domain founded_year HQ Location
CRO focused on ophthalmic drugs development services
domain founded_year HQ Location
CRO focused on clinical research and tracer development services
domain founded_year HQ Location
Delivers comprehensive preclinical services to support drug development processes.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Eyecro

Frequently Asked Questions about EyeCRO

When was EyeCRO founded?

EyeCRO was founded in 2011.

Where is EyeCRO located?

EyeCRO is headquartered in Oklahoma City, United States. It is registered at Oklahoma City, Oklahoma, United States.

What does EyeCRO do?

EyeCRO is a preclinical ophthalmic CRO whose primary offerings are retinal disease models. They specialize in ophthalmic studies of pharmacology, toxicology, efficacy, pharmacokinetics, and eyedrop formulation development. They offer their services in preclinical development areas such as formulation, study design, ocular surgery, veterinary, cell biology, and molecular biology. Their patent protected Microemulsion Drug Ocular Penetration System (MiDROPS) consists of a library of thermodynamically stable micro-emulsions which can solubilize small molecules and even extremely lipophilic molecules which can ensure delivery to both the anterior and the posterior segment after topical delivery. EyeCRO has a wide range of in vivo models for studying the effects of drugs targeted against allergic conjunctivitis ,corneal neovascularization and wound healing, dry eye, inherited retinal degeneration, light damaged rodents and several others.

Who are the top competitors of EyeCRO?

EyeCRO's top competitors include Lexitas, Humonix Biosciences and Optimal Tracers.

What products or services does EyeCRO offer?

EyeCRO offers MiDROPS®, Preclinical Models, and Toxicology Services.

Who are EyeCRO's investors?

EyeCRO has 1 investor. Key investors include HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available